Advertisement
Tech

Trump campaign adviser repeatedly misgenders Pennsylvania health official

Jenna Ellis has doubled down on her remarks after receiving pushback online.

Photo of Mikael Thalen

Mikael Thalen

Trump campaign senior legal adviser Jenna Ellis

A member of President Donald Trump’s campaign team stirred controversy online this week after misgendering a public health official.

Featured Video

Jenna Ellis, a senior legal adviser to the president’s reelection campaign, made the disparaging remark in a tweet on Monday.

“This guy is making decisions about your health,” Ellis said.

Advertisement

Ellis’ tweet included a link to a news article from May about how Pennsylvania Secretary of Health Rachel Levine, a transgender woman, had asked a reporter during a press briefing to stop referring to her as “sir.”

A backlash over the tweet ensued not long after, with many calling on Twitter to ban Ellis from the platform.

https://twitter.com/ParkerMolloy/status/1292835008315621376?s=20

Pennsylvania Governor Tom Wolf also weighed in on the controversy, accusing Ellis of hate speech.

Advertisement

“To @JennaEllisEsq and whoever else needs to hear this: Misgendering a transgender person is hate speech and it’s unacceptable,” Wolf said.

Speaking with The Hill, Pennsylvania Department of Health spokesman Nate Wardle defended Levine as well.

“Dr. Levine is laser-focused on assisting Pennsylvanians in the midst of a national pandemic,” Wardle said. “She does not have time for this nonsense.”

Advertisement

After the pushback, Ellis doubled down on her remarks in numerous follow up tweets.

Alphonso David, President of the Human Rights Campaign, (HRC) also spoke out against Ellis in a statement to numerous media outlets.

“Jenna Ellis is a bigot and Dr. Levine is a patriot—plain and simple,” David said. “Dr. Levine illustrates character and patriotism while Ellis cannot even define those terms.”

Twitter thus far has declined to take any action against Ellis’ account.

Advertisement

READ MORE:

H/T The Hill

 
The Daily Dot